The incidence and prevalence of structural heart disease has risen due to the longevity of the population, placing an economic burden on society. Over the past 20 years, treatment options for structural heart disease has significantly evolved. Advances in technology and interventional techniques have now shifted therapeutic options to include minimally invasive approaches to correct valvular heart disease. Patients with congenital heart defects are candidates for minimally invasive approaches to correct valvular heart disease. An interdisciplinary team approach using a fusion of multimodal imaging is the best approach for the treatment of this complex patient population.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cnc.2019.04.002 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!